Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver
Daniel Traum, … , Klaus H. Kaestner, Kyong-Mi Chang
Daniel Traum, … , Klaus H. Kaestner, Kyong-Mi Chang
Published February 23, 2021
Citation Information: JCI Insight. 2021;6(7):e146883. https://doi.org/10.1172/jci.insight.146883.
View: Text | PDF
Research Article Hepatology Infectious disease

Highly multiplexed 2-dimensional imaging mass cytometry analysis of HBV-infected liver

  • Text
  • PDF
Abstract

Studies of human hepatitis B virus (HBV) immune pathogenesis are hampered by limited access to liver tissues and technologies for detailed analyses. Here, utilizing imaging mass cytometry (IMC) to simultaneously detect 30 immune, viral, and structural markers in liver biopsies from patients with hepatitis B e antigen+ (HBeAg+) chronic hepatitis B, we provide potentially novel comprehensive visualization, quantitation, and phenotypic characterizations of hepatic adaptive and innate immune subsets that correlated with hepatocellular injury, histological fibrosis, and age. We further show marked correlations between adaptive and innate immune cell frequencies and phenotype, highlighting complex immune interactions within the hepatic microenvironment with relevance to HBV pathogenesis.

Authors

Daniel Traum, Yue J. Wang, Kathleen B. Schwarz, Jonathan Schug, David K.H. Wong, Harry L.A. Janssen, Norah A. Terrault, Mandana Khalili, Abdus S. Wahed, Karen F. Murray, Phillip Rosenthal, Simon C. Ling, Norberto Rodriguez-Baez, Richard K. Sterling, Daryl T.Y. Lau, Timothy M. Block, Michael D. Feldman, Elizabeth E. Furth, William M. Lee, David E. Kleiner, Anna S. Lok, Klaus H. Kaestner, Kyong-Mi Chang

×

Figure 2

Portal and lobular distribution of CD45+ immune cells quantified in chronic hepatitis B (CHB) and control liver tissues by IMC.

Options: View larger image (or click on image) Download as PowerPoint
Portal and lobular distribution of CD45+ immune cells quantified in chro...
(A) Acquired IMC images are visualized in representative pseudocolor plots and histogram with overlays to show that HepPar1+ events can be gated separately from CD45+ events, and that CD45+ events are enriched for immune markers (e.g., CD3, CD8, CD68). Far right contour plot overlay shows that CD68+CD45+ gate (red) is enriched for concurrent CD16/CD14 expression, compared with CD68–CD45+ gate (blue). (B) Representative contour plot and histogram overlays provide comparisons for portal (red) versus lobular (blue) detection of HepPar1, CD45, and/or CD3 expression, with expected lobular but not portal detection for HepPar1+ hepatocytes and both lobular and portal detection for CD45+ or CD3+ immune cells. (C) Overlay of lobular CD45–HepPar1+ (green), lobular CD45+HepPar1– (purple), and all portal (orange) events show HBsAg expression limited to CD45–HepPar1+ cells, CK19 expression limited to portal cells, and CD68 expression in both lobular CD45+HepPar1– immune cells and portal cells. (D) Tissue image reproduced with portal and/or lobular location of bile ducts, hepatocytes, and immune cells by applying x/y spatial coordinates to analyzed IMC data. (E) Scatter plots comparing %portal/total area, ALT, HBV DNA, and age relative to total, lobular, and portal CD45+ cell density per mm2 for 28 IA (red diamond) and 6 IT (blue X) subjects. A single outlier with portal CD45+ immune cell density at 43,365 was not shown graphically, although it was included in calculating the Spearman’s correlation and P values (shown in red fonts for P < 0.05). (F) Scatter plots comparing histological scores (Ishak lobular inflammation, Ishak portal inflammation, Ishak periportal hepatitis [piecemeal necrosis], Ishak fibrosis, and perisinusoidal fibrosis scores) with total, lobular, and portal CD45+ cell density per mm2 for 28 IA (red diamond) and 6 IT (blue X) subjects, with Spearman’s correlations and P values.

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts